EWP
BIO icon

Elevation Wealth Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

Elevation Wealth Partners’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.93K Buy
21
+17
+425% +$5.93K ﹤0.01% 975
2026
Q2 		$1.18K Sell
4
-15
-79% -$4.25K ﹤0.01% 1246
2026
Q1 		$5.3K Buy
+19
New +$5.47K ﹤0.01% 696
2024
Q3 		– Sell
-9
Closed -$2.46K – 485
2024
Q2 		$2.46K Buy
+9
New +$2.62K ﹤0.01% 440

Other funds holding BIO

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 19.76% 1-Year Est. Return

Elevation Wealth Partners's BIO Position: Q3 2026 in Review

Elevation Wealth Partners increased its Bio-Rad Laboratories Class A (BIO) stake by 425% in Q3 2026, buying an estimated $5.93K and bringing the position to 21 shares worth $7.93K. The position accounts for ﹤0.01% of the portfolio, ranked #975.

Elevation Wealth Partners first reported a position in BIO in Q2 2024 and has held it in 4 quarters since. 10 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

  • Elevation Wealth Partners held 21 shares of Bio-Rad Laboratories Class A worth $7.93K as of Q3 2026.
  • Elevation Wealth Partners bought 17 Bio-Rad Laboratories Class A shares in Q3 2026, an estimated $5.93K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Elevation Wealth Partners's portfolio in Q3 2026, its #975 holding.
  • Elevation Wealth Partners first reported a position in Bio-Rad Laboratories Class A in Q2 2024 and has held it in 4 quarters since.
  • 10 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.